A MULTICENTER, OPEN-LABEL, PHASE 3, RANDOMIZED TRIAL OF DUVELISIB VS INVESTIGATOR'S CHOICE (GEMCITABINE OR BENDAMUSTINE) IN RELAPSED/REFRACTORY NODAL T-CELL LYMPHOMA WITH T-FOLLICULAR HELPER PHENOTYPE
EHA Library, Kate Cwynarski,
4162297
BGB-11417-302, A PHASE?3, RANDOMIZED, DOUBLE-BLIND STUDY OF SONROTOCLAX (BGB-11417) + ZANUBRUTINIB VS PLACEBO + ZANUBRUTINIB IN PATIENTS WITH RELAPSED OR REFRACTORY MANTLE CELL LYMPHOMA
EHA Library, Marie Hughes,
4162328
OUTCOMES OF ZANUBRUTINIB COMBINED WITH POLATUZUMAB VEDOTIN, RITUXIMAB, CYCLOPHOSPHAMIDE, DOXORUBICIN, AND PREDNISONE (POLA-ZR-CHP) IN THE TREATMENT OF PATIENTS WITH EXTRANODAL (EN) DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL) IN A REAL-WORLD SETTING
EHA Library, Caixia Li,
4162340